Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.68 USD | -1.47% | +3.57% | +10.05% |
Financials (USD)
Sales 2024 * | 2.67B | Sales 2025 * | 2.79B | Capitalization | 2.06B |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | 23M | EV / Sales 2024 * | 1.65 x |
Net Debt 2024 * | 2.35B | Net Debt 2025 * | 2.12B | EV / Sales 2025 * | 1.5 x |
P/E ratio 2024 * |
-24.7
x | P/E ratio 2025 * |
95.4
x | Employees | 7,850 |
Yield 2024 * |
0.45% | Yield 2025 * |
-
| Free-Float | 26.13% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | -1.47% | ||
1 week | +3.57% | ||
1 month | +9.15% | ||
3 months | +22.12% | ||
6 months | +43.35% | ||
Current year | +10.05% |
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | Nov. 06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | Nov. 06 |
J. Buchi
BRD | Director/Board Member | 69 | Nov. 06 |
Paul Meister
CHM | Chairman | 71 | Nov. 06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 6.68 | -1.47% | 1,348,488 |
24-05-30 | 6.78 | -.--% | 1,720,272 |
24-05-29 | 6.78 | -0.15% | 2,012,847 |
24-05-28 | 6.79 | +5.27% | 2,609,323 |
24-05-24 | 6.45 | +0.16% | 948,025 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.05% | 2.06B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- AMRX Stock